Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gilead Sciences (NQ: GILD ) 72.56 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 432 Open 72.56 Bid (Size) 72.16 (1) Ask (Size) 72.55 (1) Prev. Close 72.56 Today's Range 72.56 - 72.56 52wk Range 62.07 - 87.86 Shares Outstanding 1,253,809,440 Dividend Yield 4.13% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia Today 4:00 EDT From Gilead Sciences, Inc. Via Business Wire This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now. July 21, 2024 This fund has a basket of growth, income, and value stocks. Via The Motley Fool Topics ETFs Performance YTD -12.83% -12.83% 1 Month +2.67% +2.67% 3 Month +8.38% +8.38% 6 Month -7.48% -7.48% 1 Year -6.57% -6.57% More News Read More Check Out What Whales Are Doing With GILD July 19, 2024 Via Benzinga If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names July 19, 2024 Via InvestorPlace Gilead Sciences's Options Frenzy: What You Need to Know July 11, 2024 Via Benzinga Looking Into Gilead Sciences's Recent Short Interest July 10, 2024 Via Benzinga If You Invested $1000 In This Stock 20 Years Ago, You Would Have $8,400 Today July 09, 2024 Via Benzinga Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025 July 17, 2024 From Gilead Sciences, Inc. Via Business Wire Want $3,000 In Passive Income? Invest $51,000 in These 3 High-Yield Dividend Plays July 17, 2024 Via The Motley Fool Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024 July 16, 2024 From Gilead Sciences, Inc. Via Business Wire The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024 July 15, 2024 Via InvestorPlace Key Takeaways From Gilead Sciences Analyst Ratings July 01, 2024 Via Benzinga Positive News is Driving This Cancer Drug Maker’s Stock Higher July 15, 2024 Via MarketBeat 3 Dividend Growth Stocks to Buy and Hold July 14, 2024 Via The Motley Fool Is Iovance Biotherapeutics a Millionaire Maker? July 14, 2024 Via The Motley Fool The 7 Most Undervalued Healthcare Stocks to Buy in July 2024 July 13, 2024 Via InvestorPlace 3 Underappreciated Stocks About to Break Their Chains July 11, 2024 Via InvestorPlace Oil Declines Amid Prospects Of An Agreement Between Israel And Hamas. Powell Will Address The Us Congress Today July 09, 2024 Via Talk Markets Topics Stocks Exposures US Equities 7 Cheap Biotech Stocks With Major Upside Potential July 09, 2024 Via InvestorPlace Healthcare Stocks Continue To Lag The Market-Can Anything Help ? July 08, 2024 Via Talk Markets This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday July 08, 2024 Via Benzinga Amgen, Inc. Dividend Stock Analysis July 05, 2024 Via Talk Markets FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals July 04, 2024 Via InvestorPlace Exposures Product Safety 3 Undervalued Biotech Gems With 200%+ Analyst Price Targets July 04, 2024 Via InvestorPlace 3 Magnificent Stocks Retirees Can Buy and Hold Forever July 01, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.